Health Agencies Under Fire for Alleged Suppression of Vaccine Benefit Studies

The reported censorship of scientific findings by HHS leadership threatens the foundational role of evidence-based medicine in public policy. This development signals a potential shift toward a more ideologically driven regulatory environment, impacting how pharmaceutical data is validated and shared.